Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. [electronic resource]
Producer: 20161213Description: 543-51 p. digitalISSN:- 1432-1262
- Aged
- Anemia -- blood
- Blood Transfusion
- Colonic Neoplasms -- blood
- Erythrocyte Indices
- Female
- Ferric Compounds -- therapeutic use
- Hemoglobins -- metabolism
- Humans
- Iron -- metabolism
- Length of Stay
- Male
- Maltose -- analogs & derivatives
- Postoperative Complications -- etiology
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.